Searched for
BROKERAGE SHAREKHAN
India's hospital sector enters new growth cycle as AI and capacity expansion reshape care: ReportIndia's hospital sector is set for significant growth over the next decade. Demand is rising due to increased income, insurance, an aging p...- Indian stocks are getting cheap, but is that a trap for Japan-like prolonged low returns?Indian equities are at a turning point with valuations correcting. Foreign investors are withdrawing funds due to global factors, but domes...
- Capital market stocks rally on RBI’s norm revisionCapital market stocks surged Wednesday as the RBI delayed new lender exposure rules by three months. Originally set for April 1, these norm...
- Fundamental Radar: Sales of this single drug can take Lupin’s US revenue to $1 billion in FY-26Lupin's focus on the US portfolio is to increase dollar sales to above $200 million from the earlier range of $170-190 million. Lupin recen...
- Mirae Asset looking to acquire Sharekhan to enhance presence in India: ReportThe Korean asset manager has begun due diligence on the Indian brokerage firm, the report quotes sources as saying. The select bidders are ...
- Fundamental Radar: IndusInd Bank set to grow faster than industry; Sharekhan explains whyA strong growth outlook from a well-diversified loan book with a rising share of retail loans along with healthy capital ratios gives stron...
- Bullish on auto stocks? Here are 14 ideas from Sharekhan ahead of Q2 results.The 3W and bus segments showed remarkable recovery led by the opening of schools, institutions and corporate offices
- Sharekhan launches discount broking platform 'Espresso'Espresso will charge Rs 20 per order only when clients make a profit through intraday trades across segments such as equity, F&O, commodity...
- Sharekhan wooing Robinhood investors, announces new discount brokerage platformSharekhan's new discount broking platform is called Espresso.
- Sharekhan to launch separate discount broking firm soonA discount broker provides a platform to buy and sell order at a reduced brokerage.
- Sharekhan downgrades Divi’s Laboratories to ‘hold’Putting its target price under review, Sharekhan advised investors to avoid buying the stock and wait for more clarity on the development.
- BNP Paribas completes acquisition of SharekhanThe Foreign Investment Promotion Board, which had rejected BNP Paribas’ proposal to buy Sharekhan in June this year, had approved it later ...
- Competition Commission of India approves Sharekhan-BNP Paribas dealSharekhan will join BNP Paribas’ Personal Investors division, which is a key player in retail brokerage and digital banking services.
- Alkem Labs IPO: Brokerages see good long-term potentialThe pharma company is the fifth largest in the country and generates 75 per cent of its revenue from the domestic market.
- Sharekhan deal: BNP Paribas, Geojit may rejig terms of engagementThe transaction between BNP Paribas and Sharekhan’s owners has sparked chatter that another deal might be in the offing.
- BNP Paribas pips PE team Warburg-GA to buy Sharekhan for Rs 2200 croreBNP Paribas has acquired broking firm Sharekhan for close to Rs 2240 cr. Deal was signed between shareholders of Sharekhan, BNP.
- CVCI ropes in Citigroup to find buyers for stake in Sharekhan: SourcesCiti Venture and IDFC had bought about 76% in the firm in 2007 for around Rs 620 crore, in a deal that helped promoters and private equity ...
- Baring PE acquires 12% in Sharekhan for Rs 240 crBaring Private Equity has pipped financial services giant Merrill Lynch to acquire a 12% stake in Mumbai-based brokerage firm Sharekhan in ...
- Buy L&T for target Rs 4,428: SharekhanSharekhan has recommended ‘buy’ on Larsen & Toubro for target price of Rs 4,428.
- Merrill Lynch may pick 20% stake in SharekhanPrivate equity investor Citigroup Venture Capital is diluting a part of its 75% stake in brokerage firm Sharekhan. Confluence '07
Load More
